Free Trial

Abrdn Healthcare Investors (NYSE:HQH) Plans Dividend of $0.54

Abrdn Healthcare Investors logo with Finance background

Abrdn Healthcare Investors (NYSE:HQH - Get Free Report) declared a dividend on Tuesday, May 20th, investing.com reports. Investors of record on Friday, May 23rd will be paid a dividend of 0.54 per share by the financial services provider on Monday, June 30th. This represents a yield of 13.62%. The ex-dividend date of this dividend is Thursday, May 22nd. This is a 8.0% increase from Abrdn Healthcare Investors's previous dividend of $0.50.

Abrdn Healthcare Investors has raised its dividend payment by an average of 101.6% annually over the last three years.

Abrdn Healthcare Investors Stock Up 1.1%

Shares of HQH opened at $15.84 on Tuesday. The firm's 50 day moving average price is $15.70 and its 200 day moving average price is $16.75. Abrdn Healthcare Investors has a twelve month low of $13.77 and a twelve month high of $19.79.

Hedge Funds Weigh In On Abrdn Healthcare Investors

Institutional investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC bought a new position in shares of Abrdn Healthcare Investors in the first quarter valued at approximately $166,000. Goldman Sachs Group Inc. raised its position in shares of Abrdn Healthcare Investors by 7.2% in the first quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider's stock valued at $191,000 after purchasing an additional 788 shares during the period. NewEdge Advisors LLC raised its position in shares of Abrdn Healthcare Investors by 3.0% in the first quarter. NewEdge Advisors LLC now owns 43,233 shares of the financial services provider's stock valued at $702,000 after purchasing an additional 1,274 shares during the period. Finally, Royal Bank of Canada raised its position in shares of Abrdn Healthcare Investors by 22.0% in the first quarter. Royal Bank of Canada now owns 529,826 shares of the financial services provider's stock valued at $8,604,000 after purchasing an additional 95,441 shares during the period. Institutional investors own 32.60% of the company's stock.

About Abrdn Healthcare Investors

(Get Free Report)

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

Featured Stories

Dividend History for Abrdn Healthcare Investors (NYSE:HQH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Abrdn Healthcare Investors Right Now?

Before you consider Abrdn Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.

While Abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines